Join to View Full Profile
1001 Potrero AveBldg 3San Francisco, CA 94110
Phone+1 415-206-8102
Dr. Rutishauser is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale School of MedicineClass of 2011
Certifications & Licensure
CA State Medical License 2013 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Circulating neutralizing antibodies and SARS-CoV-2 variant replication following postvaccination infections.Miguel A Garcia-Knight, J Daniel Kelly, Scott Lu, Michel Tassetto, Sarah A Goldberg
JCI Insight. 2025-03-10 - Post-intervention control in HIV immunotherapy trials.Demi A Sandel, Rachel L Rutishauser, Michael J Peluso
Current Opinion in HIV and AIDS. 2025-01-01 - Author Correction: Exploring synergies between B- and T-cell vaccine approaches to optimize immune responses against HIV-workshop report.Milton Maciel Jr, Rama R Amara, Katharine J Bar, Shane Crotty, Steven G Deeks
NPJ Vaccines. 2024-03-14
Press Mentions
- Long-Haulers Are Pushing the Limits of COVID-19 VaccinesMarch 25th, 2021
Biological 'Atlas' Shows Dual Personality for Immune Cells That Cause Type 1 DiabetesMarch 30th, 2020
Grant Support
- Multi-omic understanding of the transformed host T-cell response to HIV following therapeutic vaccinationUNIVERSITY OF CALIFORNIA AT DAVIS2023–2028
- Multi-omic understanding of the transformed host T-cell response to HIV following therapeutic vaccinationUNIVERSITY OF CALIFORNIA AT DAVIS2023–2028
- Multi-omic understanding of the transformed host T-cell response to HIV following therapeutic vaccinationUNIVERSITY OF CALIFORNIA AT DAVIS2023–2028
- Targeting HIV-specific T cell differentiation programs to enhance post-treatment control of HIVUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2022–2026
- Targeting HIV-specific T cell differentiation programs to enhance post-treatment control of HIVUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2022–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
